ACTIVE

SHANT BIOTECH

Financial year 2025 · Closed on 31/12/2025

Net result-201,5 k €-31,2 %over 1 year
Gross margin-178,1 k €-20,6 %over 1 year
Equity10,4 M €+2 034,0 %over 1 year

Identity

Source · BCE/KBO

SHANT BIOTECH is a Public limited company incorporated in 2017. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Tubize.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0680.795.389
Incorporation
07/09/2017
Legal form
Public limited company
Registered office
Avenue Léon Champagne 2
1480 Tubize · WallonieSee on map
Contributed capital
11 222 387,57 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin-178,1 k €-147,7 k €-98,7 k €-59,1 k €-44,3 k €
EBITDA-180,1 k €-149,5 k €-100,6 k €-60,5 k €-45,7 k €
Operating result-199,7 k €-153,4 k €-105,4 k €-73,9 k €-63,7 k €
Net result-201,5 k €-153,6 k €-106,2 k €-74,8 k €-63,9 k €
Balance sheet
Equity10,4 M €-538,9 k €-385,3 k €-279,2 k €-204,4 k €
Total assets11 M €9,3 M €8,1 M €6,3 M €3,4 M €
Cash1,5 M €545,9 k €282,8 k €276,3 k €209,7 k €
Debts614 k €9,9 M €8,5 M €6,6 M €3,6 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

GAGIK ABRAHAMYAN

Managing director · since 09 juillet 2024 · until 09 juillet 2030

Active

Ended mandates

GAGIK ABRAHAMYAN

Managing director · since 04 juin 2020 · until 04 juin 2026

Ended
OVIK MKRTCHYAN

Director · since 04 juin 2020 · until 04 juin 2026

Ended
ROMAN MOVSESYAN

Director · since 04 juin 2020 · until 04 juin 2026

Ended
SHANT LABORATORIES BELGIUM

Director · since 04 juin 2020 · until 04 juin 2026 · 0466.646.313

Represented by SONJA DE VISCH

Ended

Other companies at this address

Avenue Léon Champagne 2 1480 Tubize
CompanyCBE no.
0859.621.720
0736.499.323
AUSTERLITZ● Active
0830.937.632
D.C.● Active
0436.637.976
EPISPANIA● Active
0806.618.742
0472.758.303
PYRINDUS● Active
0415.525.036
RATOBLAST● Active
0798.435.209
0466.646.313
SORWA CONSTRUCT● Active
0830.944.461
0807.944.078
0646.828.662
0455.450.335
VOCABASE● Active
0475.517.160

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/08/202628/08/202530/08/202426/08/202330/08/202216/11/2021
General meeting04/06/202604/06/202504/06/202404/06/202304/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202504/06/202628/08/2026FrenchPDF
Abridged model31/12/202404/06/202528/08/2025FrenchPDF
Abridged model31/12/202304/06/202430/08/2024FrenchPDF
Abridged model31/12/202204/06/202326/08/2023FrenchPDF
Abridged model31/12/202104/06/202230/08/2022DutchPDF
Abridged model31/12/202004/06/202116/11/2021DutchPDF
Abridged model31/12/201914/12/202029/01/2021DutchPDF
Abridged model31/12/201804/06/201930/08/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

GAGIK ABRAHAMYAN

Managing director · since 09 juillet 2024 · until 09 juillet 2030

Active

Ended mandates

GAGIK ABRAHAMYAN

Managing director · since 04 juin 2020 · until 04 juin 2026

Ended
OVIK MKRTCHYAN

Director · since 04 juin 2020 · until 04 juin 2026

Ended
ROMAN MOVSESYAN

Director · since 04 juin 2020 · until 04 juin 2026

Ended
SHANT LABORATORIES BELGIUM

Director · since 04 juin 2020 · until 04 juin 2026 · 0466.646.313

Represented by SONJA DE VISCH

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares26/01/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates28/07/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates01/04/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Other11/09/2017
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-201,5 k €↓
  2. 2024
    Annual accounts 2024-153,6 k €↓
  3. 2023
    Annual accounts 2023-106,2 k €↓
  4. 2022
    Annual accounts 2022-74,8 k €↓
  5. 2021
    Annual accounts 2021-63,9 k €↓
  6. 2020
    Annual accounts 2020-49,8 k €↑
  7. 2019
    Annual accounts 2019-94,6 k €↓
  8. 2018
    Annual accounts 2018-60 k €
  9. 07/09/2017
    IncorporationPublic limited company